Winnie Su is a Nephrology physician affiliated with University at Buffalo. OpenAlex indexes 12 publications with 264 citations (h-index 9).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1306 Sweet Home Rd
Amherst, NY 142282792
Telephone
716-838-3188Provider last certified this registry record 11 May 2020.
Industry payments
6 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Otsuka America Pharmaceutical, Inc.Program year20251 payment
- Travere Therapeutics, Inc.Program year202516 payments
- Travere Therapeutics, Inc.Program year202419 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
61.1%Calcium channel blocker13.6%Amlodipine Besylate91%Nifedipine Er9%Part D<11 patientsLoop diuretic8.9%Bumetanide43%Furosemide41%Torsemide16%Part D<11 patients+ 9 more classes in this area
Metabolism & gastrointestinal
28%SGLT2 inhibitor17.4%Jardiance67%Farxiga34%Part D≥46 patientsPotassium supplement3.3%Potassium Chloride100%Part D≥19 patients+ 4 more classes in this area
Other
4.3%Phosphate Binder2.3%Sevelamer Carbonate100%Part D≥12 patientsDrugs for treatment of hyperkalemia and hyperphosphatemia1.9%Lokelma100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Treatment of prolonged tacrolimus toxicity using phenytoin in a haemodialysis patient
Journal of Clinical Pharmacy and Therapeutics
2019 - Effect of Bicarbonate-Buffered Dialysate on Ventricular Arrhythmias in Hemodialysis Patients
American Journal of Nephrology
2019 - Changes in Serum Bicarbonate Levels Caused by Acetate‐Containing Bicarbonate‐Buffered Hemodialysis Solution: An Observational Prospective Cohort Study
Therapeutic Apheresis and Dialysis
2017 - Management of hypophosphatemia in nocturnal hemodialysis with phosphate-containing enema: A technical study
Hemodialysis International
2011
Similar KOLs
Other experts from the same institution or the same specialty.
Anne Curtis, MD
University at Buffalo
Paresh Dandona, MD
University at Buffalo
Gil Wolfe, MD
University at Buffalo
Uriel Halbreich, MD
University at Buffalo
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”